fibrolamellar

fibrolamellar

/fi·bro·la·mel·lar/ (fi″bro-lah-mel´er) characterized by the formation of fibers of collagen in layers.
Mentioned in ?
References in periodicals archive ?
In addition, Blueprint Medicines continues to pursue research on a novel drug target for fibrolamellar hepatocellular carcinoma (FL-HCC).
Tragic Doyne with She was diagnosed with a rare liver cancer called fibrolamellar hepatocellular carcinoma in November 2011 and underwent surgery but months later began to feel extremely unwell again.
Unlike fibrolamellar HCC, the central scar in FNH is not a true scar, but represents a confluence of blood vessels, bile ducts, and sometimes a focal area of fibrosis.
Further investigations confirmed a liver tumour in segment IV, which was confirmed to be a fibrolamellar hepatoma.
The Oranmore student is currently cancer free but because Fibrolamellar has a 90% recurrence rate it is crucial she is monitored closely.
Only about 200 people a year worldwide are diagnosed, according to the Fibrolamellar Cancer Foundation, which helped fund the new study.
Within the superficial dermis, the prevalence of fibrolamellar hyperplasia increased from 19% in nonlymphedematous legs to 50% in stage 1 lymphedema but remained similar for stages 1-3.
ENMD-2076 is currently in Phase 2 clinical trials in multiple indications, including triple-negative breast cancer, soft tissue sarcoma, ovarian clear cell carcinomas and fibrolamellar carcinoma.
He has a rare liver cancer - fibrolamellar hepatocellular carcinoma, also known as FLL-HCC - which affects just 200 new patients around the world every year.
Differential diagnoses include hepatic adenomas and fibrolamellar HCC.
Constitutive Activation of ERK Pathway Is Associated With Tumoral Angiogenesis and Fibroplasia in Fibrolamellar Hepatocellular Carcinoma.
On the contrary, [alpha]FP levels will not be increased when hepatoblastomas are primarily composed of the small cell undifferentiated type or in most fibrolamellar carcinomas, but even some typical fetal hepatoblastomas have failed to produce detectable increases in serum [alpha]FP levels.